Company CJ Bioscience, Inc.

Equities

A311690

KR7311690002

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
14,790 ^KRW	+3.14%		+7.10%	-8.36%

2023	CJ Bioscience, Inc. announced that it has received KRW 24.033 billion in funding from CJ Cheiljedang Corporation	CI
2023	CJ Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

CJ Bioscience Inc, formerly ChunLab Inc, is a Korea-based company principally engaged in the provision of microbial bioinformatics platform and solutions. The Company mainly provides microbial bioinformatics analysis services and microbiome-based healthcare services through bioinformatics database and cloud analytics platform. The Company also develops microbiome therapies and infection diagnosis solutions.

KRW in Million	2022	Weight	2023	Weight	Delta
Microbial Analysis 75.6 %	3,433	84.3 %	4,216	75.6 %	+22.80%
Property for Rent 16.0 %	225	5.5 %	894	16.0 %	+297.68%
DB Provided 4.5 %	256	6.3 %	250	4.5 %	-2.54%
Monitoring of Intestinal Microbes, etc. 3.9 %	160	3.9 %	215	3.9 %	+34.06%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 90.5 %	3,665	89.9 %	5,046	90.5 %	+37.69%
International 9.5 %	410	10.1 %	529	9.5 %	+29.07%

Managers	Title	Age	Since
Jong-Sik Chun CEO	Chief Executive Officer	57	09-10-31
Joon-Woo Lee DFI	Director of Finance/CFO	-	-
Hyeon Kim CTO	Chief Tech/Sci/R&D Officer	53	-
Chang-Yeong Yang AUD	Comptroller/Controller/Auditor	53	-
Hye-Jin Hwang PRN	Corporate Officer/Principal	55	-

Members of the board	Title	Age	Since
Yong-Soo Jung BRD	Director/Board Member	54	-
Joon-Woo Lee DFI	Director of Finance/CFO	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	9,112,502	4,508,744 ( 49.48 %)	0	49.48 %

Name	Equities	%	Valuation
CJ CHEILJEDANG CORPORATION 45.44 %	4,140,899	45.44 %	49 M ₩
Jong-Sik Chun 5.079 %	462,859	5.079 %	5 M ₩

CJ Bioscience, Inc.

14 Sejong-Daero Grand Central Building B

100-768, Jung-gu

http://www.cjbioscience.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
CJ BIOSCIENCE, INC.	-8.36%	97.38M
IQVIA HOLDINGS INC.	+0.67%	42.19B
LONZA GROUP AG	+44.30%	40.15B
CELLTRION, INC.	-6.20%	28.31B
ICON PUBLIC LIMITED COMPANY	+6.55%	24.63B
ALNYLAM PHARMACEUTICALS, INC.	-21.66%	18.2B
MEDPACE HOLDINGS, INC.	+29.96%	12.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.57%	11.76B
UNITED THERAPEUTICS CORPORATION	+16.03%	10.4B
BIO-TECHNE CORPORATION	-4.80%	9.94B

Other Biotechnology & Medical Research